About Us

Press Releases

BodyGuardian Remote Patient Monitoring System

Advanced, wireless remote patient monitoring system to be available in early 2013

MINNEAPOLIS (December 3, 2012) - Preventice, Inc. announced today that its BodyGuardian Remote Patient Monitoring System (BodyGuardian RMS) will be commercially available in early 2013. Meanwhile, clinical trials are underway in the United States and Europe to quantify the impact of the BodyGuardian RMS on clinical care delivery. Preventice is demonstrating the BodyGuardian RMS this week at the mHealth Summit, one of the mobile health technology industry’s leading conferences, in Washington, D.C., December 3-5, 2012.

Read full article >

Samsung provides specialized Galaxy S II smartphone for Preventice remote patient monitoring system

Ecosystem of technology companies connected to the BodyGuardian Remote Monitoring SystemTM continues to attract industry leaders

MINNEAPOLIS (November 29, 2012)— Samsung Telecommunications America, LLC (Samsung Mobile)1 and PreventiceTM, a leading developer of mobile health solutions and remote monitoring systems, announced today that Samsung will provide mobile phones for the new BodyGuardian Remote Monitoring System (RMS)TM from Preventice. Preventice recently announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BodyGuardian RMS, allowing Preventice to market and sell BodyGuardian to hospitals and clinics for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients.

Read full article >

STMicroelectronics and Preventice Partner to Deliver Real-World Remote Monitoring that Brings Clinical Support to Patients at Home

GENEVA and MINNEAPOLIS (October 4, 2012)—STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, and PreventiceTM, a leading developer of mobile health solutions and remote monitoring systems, announced today that ST is providing wearable body sensor technologies to power the new BodyGuardian Remote Monitoring System (RMS)TM from Preventice.  Preventice recently announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BodyGuardian RMS, allowing Preventice to market and sell BodyGuardian to hospitals and clinics for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients.

Read full article >

Preventice receives FDA clearance to market BodyGuardian Remote Monitoring System

MINNEAPOLIS (Sept. 10, 2012) —PreventiceTM, Inc., a leading developer of mobile health applications and remote monitoring systems, announced today that the U.S. Food and Drug Administration (FDA) has given the company 510(k) clearance for its BodyGuardian Remote Monitoring System (RMS).

Read full article >

eCardio Named to the Inc. 500|5000 List for Fourth Consecutive Year Inc. Magazine Unveils Its Annual Exclusive List of America's Fastest-Growing Private

HOUSTON, TX, August 22, 2012— eCardio Diagnostics www.ecardio.com announced today their inclusion on Inc. magazine’s sixth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest growing private companies. eCardio was recognized for the fourth consecutive year, ranking No. 3429 overall and No. 275 in the Health segment with a three-year sales growth of 55%. 

Read full article >

eCardio Announces Publication of Manuscript on The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care

HOUSTON, TX, February 28, 2012 — eCardio Diagnostics www.ecardio.com, a leading provider of remote cardiac arrhythmia monitoring, today announced the acceptance for publication of the manuscript titled, “The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care.” The article appears in the Arrhythmia Section of US Cardiology journal’s February issue and is currently available online (http://www.touchcardiology.com).

Read full article >